## **Core Concept**
The question tests knowledge of H2 receptor antagonists, a class of drugs used to reduce gastric acid secretion in the treatment of peptic ulcer disease. H2 blockers work by competitively inhibiting histamine's action on H2 receptors in the parietal cells of the stomach.

## **Why the Correct Answer is Right**
Famotidine is considered one of the most potent H2 receptor antagonists. It has a high potency compared to other drugs in this class, such as ranitidine, nizatidine, and cimetidine. Famotidine's high potency allows for effective control of gastric acid secretion at lower doses compared to other H2 blockers. This makes it a preferred option for treating peptic ulcer disease due to its efficacy and relatively favorable side effect profile.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Cimetidine is one of the first H2 blockers developed and has a lower potency compared to famotidine. It requires higher doses to achieve the same level of acid suppression as famotidine.
- **Option B:** Ranitidine is more potent than cimetidine but less potent than famotidine. It was a significant improvement over cimetidine but not as effective as famotidine in terms of potency.
- **Option C:** This option seems to be missing, but based on the context, if it were nizatidine, it would be less potent than famotidine. Nizatidine has a similar mechanism of action but is generally considered less potent than famotidine.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that famotidine is not only potent but also has a longer duration of action compared to some other H2 blockers, which can influence dosing frequency and patient compliance. Additionally, while all H2 blockers can have side effects, famotidine's profile is generally favorable, making it a commonly used medication for managing peptic ulcer disease.

## **Correct Answer:** D. Famotidine